| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 515 | 533 | 559 | 628 | 646 | 637 | 599 | 725 | 753 | 801 | 857 | |
| COGS | -229 | -242 | -251 | 263 | 260 | 252 | 281 | 348 | 338 | 369 | 403 |
| Gross profit | — | — | — | 365 | 386 | 385 | 318 | 377 | 415 | 433 | 454 |
| 712 | 735 | 767 | 316 | 357 | 350 | 296 | 346 | 377 | 398 | 428 | |
| 32 | 39 | 43 | 50 | 28 | 35 | 22 | 31 | 37 | 35 | 26 | |
| OPM % | 6.2% | 7.4% | 7.7% | 7.9% | 4.4% | 5.5% | 3.6% | 4.3% | 5% | 4.3% | 3.1% |
| Depreciation | — | 12 | — | 15 | 14 | 14 | 13 | 13 | 13 | 8 | 9 |
| Interest | 3 | 3 | 4 | 3 | 3 | 2 | 3 | 5 | 3 | 3 | 3 |
| 6 | 6 | 7 | 8 | 9 | 18 | 42 | 643 | 63 | 85 | 68 | |
| Profit before tax | 36 | 30 | 36 | 39 | 19 | 37 | 48 | 657 | 84 | 108 | 83 |
| Tax | 13 | 11 | — | 15 | 7 | -9 | 6 | 17 | 21 | 27 | 17 |
| Tax % | 36.2% | 35.7% | — | 37.9% | 36.6% | -25.3% | 13.2% | 2.6% | 25.3% | 24.6% | 20.5% |
| 23 | 19 | 24 | 24 | 12 | 46 | 42 | 640 | 63 | 82 | 66 | |
| PAT margin % | 4.4% | 3.6% | 4.2% | 3.9% | 1.9% | 7.3% | 6.9% | 88.2% | 8.4% | 10.2% | 7.7% |
| EPS (₹) | — | — | 25.8 | 17.3 | 8.7 | 32.9 | 29.4 | 452.7 | 44.5 | 57.8 | 46.5 |
| EPS adjusted (₹) | — | — | 16.7 | 17.3 | 8.7 | 32.9 | 29.4 | 452.7 | 44.5 | 57.8 | 46.5 |
| — | — | 19.4% | 29% | 34.4% | 18.3% | 34% | 2.2% | 22.5% | 17.3% | 21.5% | |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | — | 237 | 235 | 281 | 316 | 939 | 987 | 1,051 | 1,101 |
| — | 28 | 28 | 18 | 20 | 26 | 21 | 24 | 24 | |
| — | 136 | 154 | 182 | 209 | 191 | 178 | 192 | 190 | |
| Total equity & liabilities | — | 416 | 431 | 494 | 559 | 1,170 | 1,201 | 1,281 | 1,329 |
| 110 | 98 | 89 | 85 | 80 | 71 | 75 | 81 | 73 | |
| CWIP | — | 2 | 9 | 0 | 0 | 3 | 1 | 0 | 1 |
| Investments | — | 13 | 9 | 13 | 15 | 13 | 13 | 11 | 9 |
| — | 304 | 325 | 395 | 463 | 1,083 | 1,112 | 1,189 | 1,246 | |
| Total assets | — | 416 | 431 | 494 | 559 | 1,170 | 1,201 | 1,281 | 1,329 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Consumer Products | 241.28 | 18.35 | 50.49 | 51.44 | — | — |
| Protective Devices | 216.51 | -10.54 |
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 | 25 | 17 | 20 | 96 | 45 | -26 | -5 | -4 | -21 | |
| 5 | -23 | 10 | -13 | -77 | -31 | 33 | 28 | 20 | 52 | |
| -23 | -7 | -31 | -10 | -17 | -9 | -12 | -22 | -18 | -18 | |
| Net cash flow | 0 | -4 | -4 | -4 | 2 | 5 | -6 | 2 | -2 | 13 |
| Free cash flow | 12 | 21 | 13 | 8 | 95 | 39 | -38 | -15 | -17 | -27 |
| CFO / Operating profit % | 45.3% | 58.6% | 34.9% | 70.1% | 276.4% | 206% | -83.2% | -13.2% | -11.4% | -80.8% |
| 148.05 |
| 46.3 |
| 101.75 |
| -10.36 |
| Foods | 151.1 | 13.43 | 52.55 | 15.08 | 37.47 | 35.84 |
| Animal Welfare | 141.08 | 11.92 | 43.96 | 29.24 | 14.72 | 80.98 |
| Medical Devices | 106.92 | 22.54 | 81.89 | 14.92 | 66.97 | 33.66 |
| Others | 0.39 | 0.4 | 2.99 | 1.42 | 1.57 | 25.48 |
₹ crore by fiscal year